OMNEON (Completed)
A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control
- Medicine
- MK-3102
- Population
- Diabetes mellitus
- Phase
- IIb
- Starting year
- 2010
- More information
- ClinicalTrials.gov